Cargando…
Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures
BACKGROUND: Though glioblastoma multiforme (GBM) is the most frequently occurring brain malignancy in adults, clinical treatment still faces challenges due to poor prognoses and tumor relapses. Recently, microRNAs (miRNAs) have been extensively used with the aim of developing accurate molecular ther...
Autores principales: | Yerukala Sathipati, Srinivasulu, Huang, Hui-Ling, Ho, Shinn-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260001/ https://www.ncbi.nlm.nih.gov/pubmed/28155650 http://dx.doi.org/10.1186/s12864-016-3321-y |
Ejemplares similares
-
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022) -
Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2017) -
Author Correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022) -
Identification of the miRNA signature associated with survival in patients with ovarian cancer
por: Sathipati, Srinivasulu Yerukala, et al.
Publicado: (2021) -
Survival associated miRNA signature in patients with head and neck carcinomas
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2023)